Page last updated: 2024-10-26

doxepin and Dyskinesia Syndromes

doxepin has been researched along with Dyskinesia Syndromes in 1 studies

Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ehrensing, RH1

Other Studies

1 other study available for doxepin and Dyskinesia Syndromes

ArticleYear
Letter: Lithium and M.R.I.H. in tardive dyskinesia.
    Lancet (London, England), 1974, Dec-14, Volume: 2, Issue:7894

    Topics: Administration, Oral; Animals; Antipsychotic Agents; Carbonates; Depression; Doxepin; Drug Therapy,

1974